
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PP1β CRISPR/Cas9 KO Plasmid (m) | sc-422378 | 20 µg | $397.00 |
Ppp1cb encodes protein phosphatase 1 beta (PP1β), a catalytic subunit of serine/threonine protein phosphatase 1 that counterbalances kinase signaling by dephosphorylating diverse substrates in a context-dependent manner. PP1β participates in regulation of cell-cycle progression, cytoskeletal dynamics, and metabolic control through holoenzyme assembly with targeting and inhibitory subunits that direct subcellular localization and substrate specificity. In mouse systems, PP1β-linked phosphoregulation is commonly studied in pathways governing chromatin organization, mitotic exit, and stress-responsive signaling. Dysregulated PP1 activity and altered PP1β-containing complexes are frequently investigated for their roles in aberrant proliferation, neurobiological processes, and cardiometabolic phenotypes as mechanistic correlates in disease models.
PP1β CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Ppp1cb gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Ppp1cb together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Ppp1cb open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish PP1β protein expression.
This CRISPR knockout system enables efficient generation of Ppp1cb-deficient cell models for investigation of PP1β signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.